The FDA granted accelerated approval on Aug. 13 to Bristol Myers Squibb’s Zenbexus (iberdomide), used with Darzalex and dexamethasone, for adults with multiple myeloma who have had at least one prior line of therapy. It is the first approval in the CELMoD class — oral agents that recruit the cell’s own disposal machinery to degrade…

FuzeHub, in partnership with Empire State Development’s NYSTAR division, announced the 2026 winners of the Jeff Lawrence Innovation Fund, awarding $650,000 total ($65,000 each) to 10 collaborative projects pairing New York nonprofits or universities with manufacturing/tech companies across the state. This was a record year with 59 applications received. Several winners are directly relevant to…

NewYorkBIO, the leading advocate of New York’s life science community, and Life Science Cares today announced a strategic relationship to advance both the growth of New York’s life science ecosystem and support underserved communities across the state. Through this collaboration, the two organizations will mobilize the life science sector to drive community impact – connecting…

Empire State Development (ESD) announced Weill Cornell Medicine and the University at Albany as the inaugural grant recipients for the New York Global Entrepreneurs Program (NYGEP). Administered by ESD’s Division of Science, Technology & Innovation (NYSTAR), the program aims to attract and retain the most promising international founders launching innovative startups in New York instead…